In prostate cancer, reduced PDH expression was significantly correlated with poor prognosis; its knockout in prostate cancer cells significantly decreased OXPHOS and increased anaerobic glycolysis, promoted stemness and migratory capabilities, and induced chemoresistance [126]. This evidence concerns the gene PDP1 and prostate cancer.